<?xml version="1.0" encoding="UTF-8"?>
<p>CAP is of use in dermatological disease and chronic wounds and has demonstrated adenoviral type-dependent antiviral effect that may be of benefit.
 <xref rid="CIT0100" ref-type="bibr">100</xref> N-chlorotaurine, an endogenous antimicrobial agent, has been shown to shorten duration of illness and is well tolerated in in vitro and in vivo experiments; however, Phase II clinical trials were prematurely ended due to inability to meet primary and secondary endpoints.
 <xref rid="CIT0101" ref-type="bibr">101</xref> These endpoints included clearing of bulbar conjunctiva, eradication of virus from tear film, fellow eye involvement, reduction of SEIs, and clearing of vision.
 <xref rid="CIT0102" ref-type="bibr">102</xref> BAK is a commonly found preservative in ophthalmic formulations typically present as 0.01% concentration. Studies prove the effectivity of BAK as an antiviral agent against adenovirus in concentrations higher than 0.1%; however, note the disadvantage of ocular toxicity from the known disinfectant.
 <xref rid="CIT0103" ref-type="bibr">103</xref>
</p>
